# Referral Guidance for Surgical Oncology Patients

**Lymph node biopsies**- Surgical Oncology

**Abdominal issues in cancer patients:**

1. Patient established with UNMC surgical oncology division for malignancy, seen within three years, and issue is related to previous intervention (for example, SBO) - *Surgical oncology*
2. Presenting manifestation related or likely related to primary malignancy - *Surgical Oncology or to the appropriate Cancer focused surgery team (e.g., colorectal)*
1. If discovered intraoperatively, Surgical Oncology consultation is at discretion of EGS staff


<span style="mso-bidi-font-family: Aptos; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>i.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>If surgical oncology assumes care intraoperatively - *Surgical oncology*

<span style="mso-bidi-font-family: Aptos; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>ii.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>If malignancy determined to not change treatment strategy - *EGS*

3. General surgical conditions (symptomatic cholelithiasis or acute/chronic cholecystitis, acute appendicitis, incarcerated hernia, small bowel obstruction) in patient with active cancer issue (on or off active treatment) or history of malignancy – EGS

Approved by Josh Mammen, MD and Hillman Terzian, MD 6/25/2025